Not a good buy right now for an impatient entry: the stock just gapped higher on earnings and is technically stretched (RSI 95) and sitting just below a key resistance zone (148.46).
Fundamentals and guidance are strong, and analyst targets moved up, but the current setup favors a near-term pullback/mean reversion rather than immediate upside.
Hedge fund and insider activity skew negative (both net selling), which reduces the attractiveness of chasing the post-earnings spike.
Technical Analysis
Strong bullish momentum: MACD histogram positive and expanding (4.056), confirming an ongoing upswing.
Overbought/extended: RSI(6) ~94.7 signals an overheated move after the earnings jump; probability of short-term digestion is elevated.
Price is near resistance: R2 ~148.459 vs current ~147.17 (limited room to resistance overhead).
Key levels: support/pivot ~121.885 (major), R1 ~138.311 (now likely support after breakout), R2 ~148.459 (near-term cap).
Pattern-based odds: +1.56% next day (70% chance), but -5.18% next week and -3.62% next month suggests post-gap fade risk.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning (open interest) is slightly defensive: OI put/call = 1.1 (more puts than calls outstanding).
Volatility: IV30 ~33.83 vs HV ~61.9 implies options are not pricing the same magnitude of realized swings seen recently; IV percentile ~55.8 (mid-range).
Liquidity/activity: today’s OI vs 30D avg ~126.85% (elevated positioning), but today’s volume is ~77.3% of 30D average (not a major volume spike).
Technical Summary
Sell
4
Buy
11
Positive Catalysts
came in well above Street expectations; narrative improved around a “cleaner” earnings baseline.
Neutral/Negative Catalysts
Technical exhaustion risk after a sharp earnings-driven jump (RSI extremely overbought; price near R2 resistance).
Trading trends: hedge funds net selling (very large QoQ increase) and insiders net selling (notable MoM increase) conflict with a “chase” entry.
Net income declined YoY in the latest quarter (despite EPS growth), which can fuel skepticism about quality of earnings.
News list contains at least one item unrelated to DaVita (ezCater COO appointment), offering no direct catalyst support.
Wall Street analysts forecast DVA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for DVA is 136.5 USD with a low forecast of 130 USD and a high forecast of 143 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast DVA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for DVA is 136.5 USD with a low forecast of 130 USD and a high forecast of 143 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
3 Hold
1 Sell
Hold
Current: 149.220
Low
130
Averages
136.5
High
143
Current: 149.220
Low
130
Averages
136.5
High
143
Truist
Hold
maintain
$128 -> $158
AI Analysis
2026-02-05
New
Reason
Truist
Price Target
$128 -> $158
AI Analysis
2026-02-05
New
maintain
Hold
Reason
Truist raised the firm's price target on DaVita to $158 from $128 and keeps a Hold rating on the shares. The firm is adjusting its model to reflect the company's Q4 earnings beat and above-consensus 2026 guide, the analyst tells investors in a research note.
TD Cowen
Hold
maintain
$133 -> $144
2026-02-04
New
Reason
TD Cowen
Price Target
$133 -> $144
2026-02-04
New
maintain
Hold
Reason
TD Cowen raised the firm's price target on DaVita to $144 from $133 and keeps a Hold rating on the shares. The firm updated its model following Q4 results.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DVA
